Computed tomography (CT) of the brain has been used extensively to evaluate both supra-and infratentorial mass lesions . However, even with the use of intravenous contrast enhancement, visualization of small brainstem lesions has not been totally satisfactory . The differentiation of intrafrom extraaxial lesions has also at times proved difficult and frustrating. Computed tomography combined with intrathecal enhancement using metrizamide provides excellent delineation of the normal anatomy of the basal cisterns and brainstem [1] [2] [3] [4] . Small aberrations of the normal architecture can be easily seen allowing early diagnosis and accurate localization of small mass lesions.
Normal Anatomy
Excellent visualization of the basal cisterns is appreciated . The midbrain , pons , and medulla are well delineated by contrast in the cisterns [3] [4] [5] (fig . 1 ). These structures are analyzed for symmetry, size , and position . The fourth ventricle and its lateral recesses are filled in most studies and should be evaluated for com pre ssion or displacement ( fig  1 A) [4] . The neg ative shadow of the basil ar artery may often be apprec iated in the interpeduncular c istern ( fig . 1 B) .
Case Reports

Case 1
A 4 3-yea r-old white man had a history of progress ive headache, nausea, diffic ulty swall owing , nystagmus, and dysequilibrium . Routin e CT scan and bil ateral carotid and vertebral arteri ograms were norm al. Posterior fossa opaque cystern ogram demostrated a mass fillin g th e right ce rebell opontine angle. Th e differential d iag nosis in cluded an extraaxial ce rebellopontine angle tumor ve rsus an intraaxial pontine mass th at had expanded into th e cerebell opontine angle.
A metrizamide-enhanced CT scan demonstrated asymmetrical enlargem ent of th e right pons extending up to in volve th e right ce rebral peduncle ( fig . 2) . Thi s was consistent with th e diagnosis of an infiltrating pontine glioma.
A suboccipital c rani otomy and bi opsy of an intraaxial ri ght pontin e lesion were performed. Path ology demonstrated a grade II astrocytoma. Th e patient tolerated th e procedure we ll and subsequentl y began radiation th erapy.
Case 2
A 63-year-old white wo man was transferred from another hospital with a 2 month hi story of vertigo and dyseq uilibrium . Physical examin ati on revealed a leth argic female with spontaneous nystagmu s , a central seventh nerve defic it on th e left , and profound left hemi paresis and left hemisensory loss . Cerebell ar examination could not be perfo rm ed . A CT scan wi th and without intrave nous con trast materi al demonstrated a contrast-enhanc in g mass lesion in th e region of the pons adjacent to tentori al calcifi cati on (figs. 3 A and 3B). Thi s lesion enhanced homogenously and d ispl aced th e fo urth ve ntricle to the lefl. Because of its proximity to the tentori al incisura, the differential diag noses considered were an intraaxial pontin e tumor versus an extraaxial lesion suc h as a meningioma.
A metri zamide-enhanced CT scan demonstrated asymmetri c enlargemen t of the rig ht pons with compression of the right cere bellopontine angle cistern and displacement to th e left of the metrizami de-fill ed fourth ve ntri c le ( fig. 3C ). Sli ghtly more cepha lad sections demonstrated th e mass ex tending into th e ce rebral peduncle and co rpus quad rig emina on th e right (fi gs. 3 D and 3 E) .
A posterior fossa explorati on was performed and the pons was found to be enlarg ed and hypovascular. Necroti c-appea ring ti ssue wa s obtained fro m a pontine biopsy and sent for perm anent section. Path ology revealed evid ence of old and new hemorrhage. Th e presum ptive diag nosis was hemorrhage and necrosis in to a pontine tumor . Po stoperati ve ly th e pati ent' s neurologic and respiratory statu s deteri o rated, and she died several weeks after surgery. No autopsy was perform ed.
Discussion
Before the advent of CT, pneumoencephalography and ce rebral angiography were the traditional methods for evaluating brain stem lesions. These procedures req uired a great deal of time and certain amount of risk and discomfort to the patient. Sma ll lesions were often diffi c ult to detect and loca lize acc urately. Computed tomography with intravenous contrast enhancement has aided considerably in the early detection and localization of these lesions [6] . However, masses in this reg ion are so metimes not identified . The basal cisterns around the pons and midbrain are 1-10 mm wide with little difference in atten uation coefficient between cerebrospin al fluid and brain . M etrizamide in the basal cisterns markedly increases their attenuation so th at high contrast is provided between the c isterns and brainstem . This markedly improves resoluti on and dec reases artifact [4] .
When les ions are identified with conventional CT , localization and differentiation between intra-and extraa xial lesion s is often difficult. Because of the excellent visualization of the c istern s and architecture of the brainstem with metrizamid e en han ced CT, differentiation between intra-and extraax ial lesions can be made more reliably . Further, the exact localizati on and extent of lesions can be defined .
Adverse reactions to intrathecal metrizamide used for c o intracran ial CT scanning are the same as those observed with metrizamide used for routine lumbar myelography. These inc lud e headache, nausea, and vomiting, with usually a 3-6 hr delay time [4, 6] . These side effects are usually mild and last no longer than 24 hr. The total metrizamide dose is less than in lumbar myelography. Numerous animal experiments have demonstrated the low epi leptogenic effect of metrizamide in the intracran ial subarachnoid space [6] . The results of recent stud ies in the literature using intracrani al metrizamide in humans also shows no significant difference in side effects between intracranial metrizamide and routine metrizamide lum bar myelography [4 , 6] . Metrizamide-enhanced CT scanning offers a rapid, safe method of evaluating the brainstem . In the evaluation of a patient suspected of a mass lesion in the brainstem, routin e CT with intravenous contrast material should be performed . Demonstration of a mass lesion can provide valuable diagnostic information. However, metrizamide CT may clarify the exact site and extent of the lesion. A normal CT scan does not exclude a brain stem lesion , and if c lini ca l sign s warrant furth er investig ati on metrizamid e-enh anced CT should be th e next step in di agn osti c evalu ation . With th e advent of more sophi sti cated CT sca nners and multi pl anar reco nstruc tion , th e info rm ati on o btain ed with metrizami de CT scanning may be sufficient to eliminate th e necess ity fo r furth er studi es in many cases.
